Compensatory changes in GroEL/Gp31 affinity as a mechanism for allele-specific genetic interaction by Richardson, A. et al.
Compensatory Changes in GroEL/Gp31 Affinity as a Mechanism for
Allele-specific Genetic Interaction*
(Received for publication, August 24, 1998, and in revised form, October 5, 1998)
Alexandra Richardson‡§, Saskia M. van der Vies‡¶, France Keppel‡, Abida Taheri,
Samuel J. Landryi, and Costa Georgopoulos‡
From the ‡De´partement de Biochimie Me´dicale, University of Geneva, 1 rue Michel-Servet, 1211 Geneva, Switzerland and
iDepartment of Biochemistry, Tulane University School of Medicine, New Orleans, Louisiana 70112
Previous work has shown that the GroEL-GroES in-
teraction is primarily mediated by the GroES mobile
loop. In bacteriophage T4 infection, GroES is substi-
tuted by the gene 31-encoded cochaperonin, Gp31. Using
a genetic selection scheme, we have identified a new set
of mutations in gene 31 that affect interaction with
GroEL; all mutations result in changes in the mobile
loop of Gp31. Biochemical analyses reveal that the mo-
bile loop mutations alter the affinity between Gp31 and
GroEL, most likely by modulating the stability of the
GroEL-bound hairpin conformation of the mobile loop.
Surprisingly, mutations in groEL that display allele-spe-
cific interactions with mutations in gene 31 alter resi-
dues in the GroEL intermediate domain, distantly lo-
cated from the mobile loop binding site. The observed
patterns of genetic and biochemical interaction be-
tween GroES or Gp31 and GroEL point to a mechanism
of genetic allele specificity based on compensatory
changes in affinity of the protein-protein interaction.
Mutations studied in this work indirectly alter affinity
by modulating a folding transition in the Gp31 mobile
loop or by modulating a hinged conformational change
in GroEL.
Chaperonin-assisted folding of certain substrates depends on
the coordinated interaction of GroEL, ATP, and GroES (1, 2).
Certain unfolded or partially folded polypeptides bind to
GroEL, a double-toroid, tetradecameric protein composed of
58-kDa subunits arranged with 7-fold symmetry (3–5). GroES,
made up of 10.5-kDa subunits arranged in 7-fold symmetry (6,
7), binds to GroEL, thus stabilizing a conformational change
that doubles the substrate-containing cavity of GroEL and
promoting the release of the substrate into the cavity (8, 9). The
amount of time the substrate spends in the cavity depends on
the rate of ATP hydrolysis in the GroEL cis ring and the release
of GroES (10, 11). In turn, the release of GroES is promoted by
the binding of ATP or ATP and GroES to the trans GroEL ring
(11, 12). After GroES release, the polypeptide substrate is
released either in a folded or a folding-competent state or in a
conformation still recognizable by GroEL, in which case it
binds to the same or a different GroEL molecule (13). The
efficient cycling of the GroE chaperone machine is essential to
ensure that the chaperonin can provide the necessary folding
assistance to its substrates (14–16).
GroEL is essential for bacteriophage T4 growth. The mutant
groEL44(E191G) allele has been shown to block bacteriophage
T4 growth at the level of capsid head assembly, i.e. in
groEL44(E191G) mutant cells, Gp23, the major capsid protein,
aggregates into amorphous lumps (17). The same phenotype
was previously observed during infection of a wild type host by
a bacteriophage T4 defective in gene 31 (18). Subsequent anal-
yses of genetic suppressors identified an interaction between
the host groEL gene and the bacteriophage T4 gene 31 (19).
It turned out that Gp31 is functionally analogous to GroES
despite low sequence identity (14% at the amino acid level) (20,
21), and it can completely replace GroES for Escherichia coli
growth.1 The crystal structures of GroES and Gp31 reveal
significant structural identities as expected from their similar
in vivo and in vitro function (6, 22). Both GroES and Gp31
subunits bear a flexible polypeptide segment, identified by
nuclear magnetic resonance (NMR) spectroscopy and limited
proteolysis (23, 24). The mobile loops mediate GroEL-GroES
binding through a central hydrophobic tripeptide (Ile25-Val26-
Leu27) as shown by NMR studies and confirmed by the crystal
structure of the GroELzADPzGroES complex (8, 23).
All mutations identified thus far in either groES or gene 31,
which result in defective GroEL interaction, alter amino acid
residues in the mobile loop. Interestingly, most of these GroES
substitutions do not affect the IVL tripeptide. Rather, the best
characterized groES mutant alleles affect either of the two
glycine residues preceding the IVL residues (25) and that par-
ticipate in formation of a b-hairpin turn (24). Bacteriophage T4
gene 31 mutant alleles affect a number of residues in the
mobile loop including residue Leu35, corresponding to Ile25 in
the GroES mobile loop (26).
Mutations in groEL, originally identified on the basis of
blocking bacteriophage growth, affect residues that are distant
from the mobile-loop binding site. The affected residues lie in
the intermediate domain that links the ATP binding equatorial
domain with the substrate and GroES binding apical domain
(23). The GroELzADPzGroES crystal structure revealed that
the intermediate segment, in fact, provides two hinges that
allow for the large en bloc movements in GroEL, which are
captured by GroES binding (8). Genetic analyses have revealed
that groEL mutations fall into two classes on the basis of their
allele-specific interaction with groES (25, 27) or gene 31 (17)
mutations. The study concerning GroEL-Gp31 interaction re-
vealed that of two groEL mutants that block bacteriophage l
growth, groEL44(E191G) and groEL515(A383T), only the former
blocks bacteriophage T4 growth. Surprisingly, mutations in gene
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31, that restore bacteriophage T4 growth on groEL44(E191G),
simultaneously prevent plaque formation on groEL515(A383T).
Understanding how specific mutations in these genes affect
chaperone function is the overall aim of the work described in
this paper. Taking advantage of a simple genetic selection
system, we have identified new mutations in gene 31 of bacte-
riophage T4 that switch the phenotype from suppression of
groEL44(E191G) to suppression of groEL515(A383T). Bio-
chemical analyses reveal that these gene 31 mutations exert
their effects primarily by altering the affinity of Gp31 for
GroEL.
EXPERIMENTAL PROCEDURES
Genetic Selection—Twenty independent lysates of the original
T4e1(Gp31(L35I)) mutant were plated separately on groEL515(A383T)
bacteria. Plaque formers, occurring at a frequency of approximately
1026 were isolated, restreaked, and characterized for plating ability on
different groEL mutant hosts. The minimal gene 31 was amplified by
polymerase chain reaction using Dynazyme Taq polymerase from a
plaque isolated from a groEL515(A383T) lawn, and the polymerase
chain reaction product was sequenced directly using the Amersham
Pharmacia Biotech Delta Taq sequencing kit (28). All 20 suppressors
sequenced contained the original e1 mutation (L35I) and in addition
had a mutation that altered a second amino acid residue, also localized
in the mobile loop. Twelve of these pseudorevertants had a mutation
that resulted in a change at codon 31 of Thr to Ala, and two candidates
had a change at the same site from a Thr to an Ile.
Cloning of Wild Type and Mutant Genes—Mutant gene 31(L35I,
T31A) was amplified by polymerase chain reaction; the polymerase
chain reaction fragment was cloned into the EcoRI and XbaI sites of the
high copy pBAD vector pMPM201 (29), and the resulting clone overpro-
ducing Gp31(L35I,T31A) was named pALEX5. The wild type gene 31
was cloned in the same manner, except the amplification was done from
a wild type T4 plaque isolated on a B178 lawn, and the resulting clone
was named pALEX1. The Gp31(I36W) protein was overproduced from
pALEX32, created by the introduction of the corresponding mutation,
resulting in I36W by site-directed mutagenesis (30) using pALEX1 as
the template. Mutant gene 31 (L35I) was made by site-directed mu-
tagenesis (30) using the plasmid pSV25 (wild type gene 31) as the
template (20). All clones were sequenced in their entirety using either
the standard Sanger sequencing method or automated sequencing
(Li-CORE).
pBADgroESgroEL is a plasmid that expresses the wild type groES
and groEL genes under the control of the arabinose-induced promoter.
The groES and groEL genes were cloned as a 2.1-kilobase pair fragment
from pOFx62(27) containing 45 base pairs upstream of the starting
ATG codon. The fragment was cloned into pBAD22 (31).
Plasmid pBADgroESgroEL(A383T), used to overexpress GroEL-
(A383T), was constructed by replacing the BstXI-SmaI fragment from
pBADgroESgroEL with the corresponding BstXI-SmaI fragment from
plasmid pOF1153 (27). The authenticity of the clone was verified by
sequencing 300 base pairs around the altered codon.
Protein Purification—Wild type GroEL and GroES were overex-
pressed from pBADgroESgroEL transformed into MC1009 cells and
induced with arabinose and purified essentially as described previously
(23). Residual peptides bound to GroEL were removed by Affi-Gel Blue
chromatography in the presence of buffer containing 50 mM Tris-HCl,
pH 7.5, 125 mM NaCl, 1 mM ATP, and 2.5 mM MgCl2 followed by MonoQ
chromatography to remove GroEL-associated nucleotide (buffer: 20 mM
Bis-Tris, pH 6.0, 50 mM-1M KCl gradient).
GroEL(A383T) was overproduced from pBADgroESgroEL(A383T)
transformed into groEL515(A383T) cells, and GroEL(E191G) was over-
produced from pJZ548(27) transformed into the groEL44(E191G) mu-
tant background. Both mutant proteins were purified following the
same procedure as that used for wild type GroEL.
Gp31, Gp31(L35I), Gp31(L35I,T31A), and Gp31(I36W) were purified
from the overexpressing plasmids described above, all in the MC1009
genetic background. The purification procedures used were identical to
those previously described (20). The expected molecular mass of wild
type Gp31, Gp31(L35I,T31A), and Gp31(I36W) were confirmed by elec-
trospray mass spectroscopy.
All proteins were stored at 280 °C in a buffer containing 50 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, and 15% (v/v)
glycerol. Protein concentrations were measured by either absorption at
280 nm using molar extinction coefficients determined by quantitative
amino acid analysis or by the Bradford protein assay method, standard-
ized with known concentrations of either GroEL or Gp31.
Citrate Synthase Refolding—The chaperonin-dependent renatur-
ation of pig heart citrate synthase (referred to in the text as citrate
synthase) was performed as described previously (32). The following
protein concentrations (given for monomers) were used: 4.2 mM chaper-
onins and cochaperonins and 0.2 mM citrate synthase. Citrate synthase
at 33 mM was denatured for 30–60 min at 27 °C in a solution containing
6 M guanidine hydrochloride, 3 mM dithiothreitol, and 2 mM EDTA. The
refolding buffer contained 10 mM MgCl2, 2 mM ATP, 1 mM oxaloacetic
acid, and 20 mM potassium phosphate, pH 7.4. The refolding reaction
was performed at 27 °C in a total volume of either 200 ml or 400 ml, and
citrate synthase activity was measured after 60 min.
Complex Formation—Complex formation was initiated by adding
ATP to a final concentration of 1 mM to a solution containing 50 mM
Tris-HCl, pH 7.7, 7.8 mM MgCl2, 1 mM KCl, 1 mM dithiothreitol, 8.4 mM
GroEL, and 35.2 mM Gp31 (monomers). The reaction mixture (250 ml)
was left at 22 °C for 10 min. An aliquot of 200 ml was loaded onto a TSK
3000G gel-fitration column that had been equilibrated in 50 mM Tris-
HCl, pH 7.7, 10 mM MgCl2, 1 mM KCl, 0.01% (w/v) Tween 20, and 0.23
mM ATP. The column was run at 22 °C at a flow rate of 1 ml/min. The
fraction between 10.5 and 11.5 min was collected. Samples were ace-
tone-precipitated and analyzed by means of electrophoresis on a 15%
polyacrylamide gel containing SDS. The proteins were stained with
Coomassie Brilliant Blue.
Fluorescence Experiments—A Photon Technologies Inc. Quanta Mas-
ter luminescence spectrometer with a double excitation set-up and
gloved cuvette holder maintained at 25 °C with a cooler-heater water
bath system was used for fluorescence analysis. All reactions were
performed under constant stirring and in a total volume of 2 ml. The
intensity at 337 nm was monitered as a function of time with excitation
at 295 nm and all slits adjusted to 4 nm. The following protein concen-
trations were used (in monomers): 2.0 mM GroEL, 1.4 mM Gp31(I36W),
and 1.4 mM Gp31 and its mutant variants. ATP was used at 1 mM with
a buffer containing 100 mM Tris-HCl, pH 7.5, 1 mM MgCl2, and 1 mM
dithiothreitol. Data were initially analyzed in Felix software provided
with the spectrometer and converted into a Kaleidagraph for presenta-
tion. The background fluorescence intensity contribution associated
with nontryptophan-containing proteins (expressed as a percentage of
the fluorescence intensity for Gp31(I36W) alone)) was subtracted ac-
cordingly: GroEL, 20%; Gp31, 8%, Gp31(L35I), 5%; Gp31(L35I,T31A),
6%.
Transferred Nuclear Overhauser Effect (trNOE)2 NMR Analysis—
Carboxamide peptides corresponding to the mobile loops of Gp31,
Gp31(L35I), and Gp31(L35I,T31A) were synthesized using 9-fluorenyl-
methoxycarbonyl chemistry, acetylated off-line, and purified by re-
verse-phase high preformance liquid chromatography. Sequences are as
follows: Gp31, AQAGDEEVTESGLIIGKRVQ; GP31(L35I), AQAG-
DEEVTESGIIIGKRVQ; GP31(L35I,T31A), AQAGDEEVAESGIIIG-
KRVQ. Peptide sequences were confirmed by matrix-assisted laser de-
sorption ionization mass spectrometry (MALDI). GroEL and
GroEL(E191G) were exchanged and concentrated into a 50 mM potas-
sium phosphate, pH 6.1, buffer (Centricon-30, Amicon). GroEL was
added to a final concentration of 60 mM in an NMR sample containing 2
mM peptide, 10% D2O, and 0.3 mM trimethylsilyl proprionate in 50 mM
potassium phosphate, pH 6.1, buffer. Spectra were recorded at 30 °C on
a General Electric OMEGA PSG 500 NMR spectrometer operating at
500.05 MHz frequency. Data were processed as described previously
(24) using Felix software (Biosym Technologies, San Diego, CA) run-
ning on a Silicon Graphics Indigo (Mountain View, CA) work station.
RESULTS
groEL/Gene 31 Allele-specific Mutations Fall into Two
Classes—Previous work has shown that bacteriophage T4 mu-
tations, which restore growth on groEL44(E191G) map to gene
31 (17), and sequencing of one candidate, called T4e1, showed
that the mutation in gene 31 results in an amino acid change at
codon 35 from Leu to Ile (26). This apparently subtle change in
Gp31 resulted in a strikingly different genetic interaction with
GroEL, because T4e1 simultaneously lost its ability to plaque
on groEL515(A383T) mutant bacteria. We took advantage of
the finding that T4e1 does not grow on groEL515(A383T) mu-
tant bacteria to isolate spontaneously occurring, bacterio-
2 The abbreviation used is: trNOE, transferred nuclear Overhauser
effect.
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phage-encoded suppressors. From 20 independent T4e1 lysates
plated on groEL515(A383T), bacteriophage “revertants” capa-
ble of forming a plaque were isolated at a frequency of approx-
imately 1026. All revertants simultaneously lost their capacity
to propagate on groEL44(E191G) mutant bacteria. Sequence
analysis showed that all 20 candidates retain the original e1
mutation (Leu to Ile at codon 35). The most frequently occur-
ring suppressor mutation (12 of 20 isolates) resulted in a sub-
stitution at codon 31 of Thr with Ala, and two additional
revertants were shown to alter the same codon to an Ile (Table
I). Significantly, the genetic interaction between residues 35
and 31 in the mobile loop of Gp31 coincides with the physical
interaction observed in the GroEL-bound conformation deter-
mined by trNOE NMR (Fig. 5B) (24).
Mutations in groEL and Gene 31 Affect Chaperonin-assisted
Refolding of Citrate Synthase—Previous work has shown that
citrate synthase depends on both GroEL and GroES for rena-
turation (32). In the absence of chaperonins, only 10–20% of
denatured citrate synthase regains activity. GroEL alone (with
ATP) inhibits refolding of citrate synthase (Fig. 1). In contrast,
GroEL paired with GroES, Gp31, Gp31(L35I), or Gp31(L35I,
T31A) efficiently helps citrate synthase refolding. Likewise,
GroEL(E191G) inhibits refolding of the substrate in the ab-
sence of a cochaperonin but assists citrate synthase refolding
with GroES. However, when paired with Gp31, GroEL(E191G)
is unable to assist refolding. As anticipated from our in vivo
genetic analysis, Gp31(L35I) restores chaperonin-assisted fold-
ing by GroEL(E191G), whereas Gp31(L35I,T31A) and
GroEL(E191G) form a nonfunctional pair for the refolding of
citrate synthase.
The above results indicate that citrate synthase refolding
depends on functional interaction between GroEL and Gp31,
strongly suggesting that the observed defects in bacteriophage
T4 growth are also the result of aberrant chaperone-assisted
folding. What is the molecular basis of the defect in chaperonin-
cochaperonin interaction? The amino acid substitutions in
Gp31 or GroEL could increase or decrease their affinity for
each other. To test this, we analyzed complex formation by gel
filtration chromatography.
The L35I Substitution in Gp31 Restores Binding to
GroEL(E191G)—Formation of the GroELzGp31 complex re-
quires nucleotide and can be observed by size fractionation on
gel filtration chromatography (Fig. 2A). With the same condi-
tions, GroEL(E191G) does not form a complex with Gp31 (Fig.
2B). Therefore, the inability of GroEL(E191G) to assist citrate
synthase refolding when paired with Gp31 is most likely be-
cause of a lack of stable chaperonin-cochaperonin complex for-
mation. However, GroEL(E191G)zATP does form a stable com-
plex with Gp31(L35I) (Fig. 2C). Thus, we conclude that the
substitution in Gp31(L35I) increases the affinity of Gp31 affin-
ity for GroEL, and we hypothesize that Gp31(L35I,T31A) de-
creases the affinity of Gp31 for GroEL. To test this, we devel-
oped a technique to distinguish subtle differences in GroEL
binding between Gp31 and Gp31 mutants.
Relative GroEL-binding Affinities of Gp31 Mutants Deter-
mined by Competition with a Fluorescent Gp31 Variant—Tryp-
tophan fluorescence may be exploited to measure protein-pro-
tein interactions provided that the tryptophan undergoes an
environmental change upon formation of the complex. Because
neither GroEL, GroES, nor Gp31 contain tryptophan residues,
we sought to introduce one such that it would report Gp31
binding to GroEL. Gp31(I36W) was created by site-directed
mutagenesis. Ile36 is the central residue of the hydrophobic
tripeptide, Leu35-Ile36-Ile37, in the Gp31 mobile loop.
Gp31(I36W) interacts with GroEL in a manner similar to wild
type Gp31, consistent with the fact that it can substitute for
wild type Gp31 in bacteriophage T4 growth. However, unlike
TABLE I
Plating ability of various bacteriophage T4 mutant strains at 37 °C
The ability of bacteriophage T4 wild type and its gene 31 mutant
derivatives to form plaques on various E. coli hosts at an approximate
efficiency of 1.0 is denoted as 1. The inability to form plaques on a given
bacterial host is denoted as 2. However, at a frequency of 1026–1027,
spontaneously occurring revertants can be isolated as plaque-formers
on the various nonpermissive bacterial hosts.
groEL
wild type
groEL44
(E191G)
groEL515
(A383T)
T4 wild type 1 2 1
T4 31(L35I) 1 1 2
T4 31(L35I,T31A) 1 2 1
12 of 20 isolates
T4 31(L35I,T31I) 1 2 1
2 of 20 isolates
FIG. 1. Chaperonin-dependent refolding of citrate synthase.
The yield of folded protein is expressed as a percentage of nondenatured
citrate synthase activity. Citrate synthase activity was measured after
60 min of refolding at 27 °C with the indicated combinations of chap-
erones, as described under “Experimental Procedures.” Data presented
are the average and S.E. of three separate experiments.
FIG. 2. Complex formation of mutant and wild type GroEL and
Gp31 proteins. A Commassie Brilliant Blue-stained gel is presented
showing the proteins present in the GroEL-containing fraction follow-
ing chromatography on a TSK 3000G column. Lanes represent mixtures
containing: A, GroEL and Gp31; B, GroEL(E191G) and Gp31; C,
GroEL(E191G) and Gp31(L35I). The asterisk (*) indicates either wild
type or mutant protein.
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wild type Gp31, Gp31(I36W) functions with GroEL(E191G) in
citrate synthase refolding (Fig. 1). Nevertheless, Gp31(I36W)
can be exploited as a reporter to detect the relative binding
affinities of the various GroES and Gp31 proteins in a compe-
tition assay.
The fluorescence emission spectrum of Gp31(I36W) exhibits
a wavelength of maximum emission (lmax) of 347 nm, which
suggests that the introduced tryptophan side chain is solvent-
exposed (Fig. 3A). The addition of GroEL in the absence of
nucleotide results in a small increase in fluorescence intensity
and no change in emission lmax. However, further addition of
ATP results in a 2-fold increase in emission intensity as well as
a 10-nm decrease in lmax. These results suggest that the tryp-
tophan side chain is transferred to a nonpolar environment in
the GroELzGp31 complex.
The relative binding affinities of Gp31 and Gp31 mutants
can be evaluated with a binding competition assay. First, a
complex between GroEL and Gp31 is formed in the presence of
nucleotide. Subsequently, binding of Gp31(I36W) to GroEL is
monitored by tryptophan fluorescence. The extent that Gp31
blocks the change in fluorescence indicates the ability of the
Gp31 competitor to inhibit Gp31(I36W) binding.
Prior incubation of GroELzATP with Gp31 only slightly in-
hibits Gp31(I36W) binding (Fig. 3B). In contrast, Gp31(L35I)
complexed with GroELzATP effectively blocks Gp31(I36W)
binding, indicating that it is more difficult to displace than its
wild type counterpart. Gp31(L35I,T31A) in complex with
GroELzATP hinders Gp31(I36W) binding partially, neither as
well as Gp31(L35I) nor as weakly as Gp31. From these exper-
iments, the following relative order of cochaperonin binding
affinity to GroELzATP is established: Gp31(L35I) . Gp31(L35I,
T31A) . Gp31.
Because the affected residues in the GroEL mutants are
distant from the mobile loop binding site, one would expect the
same order of binding affinity on the GroEL mutants used in
this study. We tested this prediction by repeating the same
experiment while substituting GroEL with GroEL(A383T). In-
deed, the order of relative affinity remains the same (data not
shown).
Synthetic Mobile Loop Peptides Corresponding to Gp31 Mu-
tants Recapitulate Altered GroEL Binding—Above we showed
that mutations that affect residues in the mobile loop of Gp31
alter its affinity for GroEL. To establish that these differences
are a direct result of changes in the mobile loop binding to
GroEL, we compared the GroEL binding properties of synthetic
peptides corresponding to the mobile loops of our Gp31 mu-
tants by analysis of trNOEs. The appearance of trNOEs in the
NOESY spectra of the three peptides in the presence of GroEL
indicates that each binds to GroEL (Fig. 4). However, the
Gp31(L35I) peptide exhibits more intense trNOEs compared
with those of Gp31 and Gp31(L35I,T31A) peptides, suggesting
that the L35I substitution strengthens mobile loop binding to
GroEL and that the T31A substitution weakens it. In the
presence of GroEL(E191G), there is a marked decrease in
trNOEs for Gp31 and Gp31(L35I,T31A) compared with
Gp31(L35I), consistent with the lack of in vivo interaction
between GroEL(E191G) and these cochaperonins. These re-
sults indicate that the mobile loop itself can recognize the
defect in GroEL(E191G) despite the relatively large distance
between the altered amino acid residue and the mobile loop
binding site in GroEL (Fig. 5A).
DISCUSSION
GroEL-Gp31 Mutant-Suppressor Pairs Illustrate a Mecha-
nism of Allele-specific Genetic Interaction—As stated earlier,
taking advantage of a GroEL mutant, GroEL(A383T), that does
not function with Gp31(L35I), we have isolated compensatory
mutations that reveal a striking genetic interaction between
Gp31 and GroEL. Specifically, all mutants of bacteriophage T4
Gp31(L35I) isolated as restoring ability to grow on
FIG. 3. Inhibition of Gp31(I36W) binding to GroEL by Gp31
mutant proteins monitored by fluorescence. A, fluorescence inten-
sity of Gp31(I36W) is enhanced in the presence of GroEL and nucleo-
tide. Gp31(I36W) interacts with GroEL in the presence of ATP as
reported by an increase in fluorescence intensity as well as a blue shift
in lmax. Tryptophan was specifically excited at 295 nm, and its emis-
sion was recorded over the range 320 to 380 nm. l, Gp31(I36W); E,
Gp31(I36W)-GroEL; 3, Gp31(I36W)zGroELzATP. B, Gp31(I36W) was
injected into a cuvette containing a preequilibrated GroELzATPz
cochaperonin complex. a, GroEL 1 Gp31(I36W); b, GroELzGp31 1
Gp31(I36W); c, GroELzGp31(L35I,T31A) 1 Gp31(I36W); d, GroELz
Gp31(L35I) 1 Gp31(I36W); e, Gp31(I36W). Tryptophan was excited at
295 nm, and time-based emission was recorded at 337 nm. In the
absence of cochaperonin, Gp31(I36W) binds rapidly to GroELzATP. The
preaddition of Gp31 does not block binding but instead retards binding
of Gp31(I36W). The preaddition of Gp31(L35I) almost completely inhib-
its binding of Gp31(I36W), whereas the preaddition of
Gp31(L35I,T31A) inhibits Gp31(I36W) binding to GroEL by ;50%.
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groEL515(A383T) simultaneously lose their ability to grow on
groEL44(E191G). Potentially, the GroEL-Gp31 genetic interac-
tion could be ascribed to a conventional mechanism of allele
specificity, in which distinct mutant-suppressor pairs arise
from direct contacts among the affected amino acids in the
protein-protein interface (33). However, amino acids involved
in the GroEL-Gp31 genetic interactions analyzed here are lo-
cated far from each other in the GroELzGp31 complex (Fig. 5A).
Our biochemical analyses of the mutant Gp31 proteins sug-
gest that mutant-suppressor pairs complement each other by
contributing in opposite ways to GroEL-Gp31 affinity. The
relative affinities of wild type and mutant Gp31 proteins were
probed indirectly through their ability to block binding to
GroEL of a fluorescent variant of Gp31, Gp31(I36W), and by
the strength of trNOEs observed for their corresponding mobile
loop peptides in the presence of GroEL. Both assays indicate
the following relative affinity for GroEL: Gp31(L35I) .
Gp31(L35I,T31A) . Gp31. Thus, it appears that the increased
GroEL binding affinity of Gp31(L35I) compensates for the low
affinity interaction of the GroEL(E191G)-Gp31 pair, and the
reduced affinity of Gp31(L35I,T31A) compensates for the pre-
sumed high affinity interaction of the GroEL(A383T)-
Gp31(L35I) pair. The same relative affinity ranking is observed
for binding of the various Gp31 proteins to GroEL(A383T) (data
not shown) and for binding of the corresponding mobile loop
peptides to GroEL(E191G). The fact that the order of affinity is
indifferent to the GroEL protein tested supports our proposal
that the mechanism of GroEL-Gp31 genetic interactions stud-
ied here arises from compensatory affinity changes rather than
classical allele-specific alterations in the structure of the bind-
ing interface.
Amino Acid Substitutions in the Mobile Loop Affect Forma-
tion of the GroEL-bound Hairpin Conformation—As detailed
above, the predominance of substitutions at amino acid posi-
tion 31 in the pseudorevertants (14 of 20 isolates; Table I)
suggests that changes at this position have a greater potential
for counteracting the increased binding affinity caused by the
L35I substitution. Consistent with this hypothesis, previous
NMR studies detected trNOEs between the side chains of Thr31
FIG. 5. X-ray and NMR structures. A, a single subunit from the
GroELzADPzGroES crystal structure (8). The GroEL(E191G) and
GroEL(A383T) specific amino acid changes are localized in the hinges
flanking the intermediate domain of GroEL and are highlighted. B, the
structure of the GroEL-bound GroES mobile loop peptide was deter-
mined by trNOE NMR in the presence of GroEL. The Ser21 and Ile25
residues (equivalent to Thr31 and Leu35 of Gp31, respectively) interact
in the GroEL-bound conformation (24). Stuctures were modeled using
MolScript (44).
FIG. 4. Ha/upfield region of NOESY
spectra of mobile loop peptides in the
presence of GroEL. Spectra were re-
corded at 30 °C as described under “Ex-
perimental Procedures.”
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and Leu35 in the Gp31 mobile loop peptide bound to GroEL,
indicating that these side chains approach within a few ang-
stroms of each other (24). The proposed Thr31-Leu35 contact
corresponds to the Ser21-Ile25 contact observed in the GroEL-
bound GroES mobile loop peptide (23). All of the trNOE data in
the Gp31 peptide were consistent with its forming the same 3:5
hairpin conformation (using the classification of Sibanda and
Thornton (34)) as that formed by the corresponding GroES
mobile loop peptide (Fig. 5B), which places these two side
chains next to each other but on opposite strands of the hairpin.
Amino acid b-strand preferences can account for the ob-
served changes in GroEL-Gp31 binding caused by the various
mutations. A host-guest study ranked all 20 amino acids by the
change in free energy for folding of a protein in which the
substituted site was located at the edge of a b-sheet (35). This
study may be the most relevant because a b-hairpin more
closely resembles the edge than the middle of a b-sheet. It was
found that Leu is unfavorable for b-sheet formation, Ala and Ile
are neutral, whereas Thr is favorable. Thus, the L35I substi-
tution is expected to increase b-hairpin stability, whereas ei-
ther T31A or T31I are expected to decrease b-hairpin stability.
Because Gp31 binding to GroEL is coupled to b-hairpin forma-
tion, changes in GroEL binding affinity may result from
changes in b-hairpin stability. Minor and Kim (35) noted a
significant difference in the rank order of amino acids in
b-sheet propensity for substitution at the edge of a b-sheet
versus the middle of a b-sheet. In particular, Ile is a strong
b-sheet-former in the middle of a b-sheet but essentially neu-
tral at its edge. The authors suggested this is because of a
balance of a favorable contribution from side chain conforma-
tional entropy and poor hydrophobic burial at the edge of the
b-sheet. Thus, the initially surprising result that either the
T31A or T31I substitution can result in the same phenotype
can now be understood in terms of contributions to b-sheet
stability.
Our experimental results, coupled with the conclusions de-
rived from the model systems discussed above, demonstrate
that the GroEL-Gp31 genetic interaction can be understood in
the framework of a folding transition by the Gp31 mobile loop.
The mobile loop conformational dynamics must be exquisitely
poised for folding into a b-hairpin and yet sufficiently disor-
dered that GroEL binding is not too tight. As a result, seem-
ingly subtle amino acid substitutions, such as L35I, can com-
pletely rescue or block bacteriophage T4 growth depending on
the particular mutant host.
Amino Acid Substitutions in the GroEL Hinge Regions Affect
Local as Well as Large Scale Conformational Changes—Sub-
stitutions in the hinges could change the distribution of GroEL
subunits between apical domain-open and apical domain-
closed conformations and/or affect the apical domain-mobile
loop docking interaction by allosteric communication. We com-
pared the relative orientation of the three GroEL apical domain
residues that contact the mobile loop in the crystal structure of
GroELzADPzGroES with the orientation of these residues in the
crystal structure of GroEL alone (Fig. 6 (8, 36)). The orientation
of the Val264 side chain is shifted with respect to other apical
domain residues, suggesting that the a-helix containing Val264
twists when GroEL visits its open conformation. The other two
GroEL residues, Leu234 and Leu237, show minor changes in
orientation. Because mobile loop peptides exhibit reduced bind-
ing to GroEL(E191G), mobile loop and, therefore, Gp31 binding
may be controlled by the ratio of open versus closed GroEL
subunits. If the mobile loop has a lower affinity for GroEL in
the closed conformation and GroEL(E191G) visits the open
state less frequently, then poor binding of Gp31 could be be-
cause of a smaller population of GroEL(E191G) subunits in the
open state.
Implications for Protein-Protein Interaction—An affinity-
based mechanism for allele specificity has been ascribed to
other protein-protein interactions, raising the possibility that
the classical notion of allele-specificity is generally avoided by
robust, flexible protein-protein contacts. For example, suppres-
sion of defects in fimbrin-actin interactions in yeast has been
attributed to a global increase in affinity of fimbrin mutants for
actin mutants, and at least two fimbrin mutants bind more
tightly to wild type actin (37). Crystal structures of human
fimbrin and bovine actin reveal that residues affected in the
mutant yeast proteins are not only localized to surfaces of
potential protein-protein contact, and several are buried in a
hydrophobic core (38). In the bacterial chemotaxis system, in-
teraction of the response regulator CheY with the receptor
kinase CheA has been localized to a surface of CheY, but
residues in the contact surface are not evolutionarily con-
served, and crystal structures of CheY with the P2 domain of
CheA reveal at least three different modes of binding (39, 40).
In the chaperonin system, we find that mutations affecting
GroEL-Gp31 affinity modulate a folding transition in the Gp31
mobile loop. Hence, in all of these systems, residues in the
intermolecular interfaces may be less critical than residues
controlling domain folding and stability.
Strict allele-specificity may always involve a conformational
switch in one partner of a protein-protein interacting pair. In
the chemotaxis system, bias for clockwise versus counter-clock-
wise motor rotation is controlled by interactions of phospho-
CheY with the flagellar switch protein FliM. Many, if not all
mutations in FliM that suppress mutations in CheY are
thought to adjust the bias of the switch rather than restore
normal interactions with mutant CheY (41, 42). The indirect
effect of these suppressor mutations in FliM is analogous to the
effect of hinge mutations in GroEL that compensate for strong
or weak binding by mobile loop mutants in Gp31. Apparently,
a great deal of redundancy has accumulated in the structural
FIG. 6. Location of GroEL residues
directly bound by the GroES mobile
loop. Residues Leu234, Leu237, and Val264
are presented as space-filled atoms. A, a
close-up view of the apical domain in the
GroEL crystal structure (3). B, a close-up
view of the GroEL apical domain with
the GroES mobile loop in the
GroELzADPzGroES crystal structure (8).
Structures were modeled using MolScript
(44).
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features of protein-protein interactions, as has already been
appreciated in protein folding itself (43). Mutations tend to
shift conformational equilibria between broad energy minima
rather than cause distinct changes in structure.
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